SG11201400086QA - Vaccine - Google Patents

Vaccine

Info

Publication number
SG11201400086QA
SG11201400086QA SG11201400086QA SG11201400086QA SG11201400086QA SG 11201400086Q A SG11201400086Q A SG 11201400086QA SG 11201400086Q A SG11201400086Q A SG 11201400086QA SG 11201400086Q A SG11201400086Q A SG 11201400086QA SG 11201400086Q A SG11201400086Q A SG 11201400086QA
Authority
SG
Singapore
Prior art keywords
vaccine
Prior art date
Application number
SG11201400086QA
Other languages
English (en)
Inventor
Sylvia Brunner
Gergana Galabova
Bettina Wanko
Markus Windwarder
Gabriele Winsauer
Claudia Juno
Günther Staffler
Original Assignee
Affiris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affiris Ag filed Critical Affiris Ag
Publication of SG11201400086QA publication Critical patent/SG11201400086QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0012Lipids; Lipoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6454Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6081Albumin; Keyhole limpet haemocyanin [KLH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21061Kexin (3.4.21.61), i.e. proprotein convertase subtilisin/kexin type 9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11201400086QA 2011-09-13 2012-09-13 Vaccine SG11201400086QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11181090.9A EP2570135B1 (en) 2011-09-13 2011-09-13 PCSK9 Vaccine
PCT/EP2012/067950 WO2013037889A2 (en) 2011-09-13 2012-09-13 Vaccine

Publications (1)

Publication Number Publication Date
SG11201400086QA true SG11201400086QA (en) 2014-03-28

Family

ID=46851983

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201400086QA SG11201400086QA (en) 2011-09-13 2012-09-13 Vaccine

Country Status (24)

Country Link
US (2) US9220762B2 (he)
EP (2) EP2570135B1 (he)
JP (1) JP6054400B2 (he)
KR (1) KR101983685B1 (he)
CN (1) CN103874504B (he)
AU (1) AU2012307348B8 (he)
BR (1) BR112014005756A2 (he)
CA (1) CA2848487A1 (he)
CY (2) CY1117335T1 (he)
DK (2) DK2570135T3 (he)
ES (2) ES2565757T3 (he)
HR (2) HRP20160392T1 (he)
HU (2) HUE028583T2 (he)
IL (1) IL231043A (he)
LT (1) LT2755678T (he)
MX (1) MX346883B (he)
PL (2) PL2570135T3 (he)
PT (1) PT2755678T (he)
RS (1) RS54639B1 (he)
RU (2) RU2640258C2 (he)
SG (1) SG11201400086QA (he)
SI (2) SI2570135T1 (he)
SM (1) SMT201600082B (he)
WO (1) WO2013037889A2 (he)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9255154B2 (en) 2012-05-08 2016-02-09 Alderbio Holdings, Llc Anti-PCSK9 antibodies and use thereof
EP2703483A1 (en) 2012-08-29 2014-03-05 Affiris AG PCSK9 peptide vaccine
US10279019B2 (en) 2014-02-11 2019-05-07 Stc.Unm PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same
CN106459209B (zh) * 2014-02-28 2019-10-11 阿费里斯股份公司 Pcsk9疫苗
CN105085684B (zh) * 2014-05-14 2020-04-17 上海亨臻实业有限公司 Pcsk9靶向重组疫苗设计及其应用
CN106822881A (zh) * 2016-12-09 2017-06-13 四川大学 一种针对pcsk9的抗高血脂蛋白疫苗
WO2018189705A1 (en) 2017-04-13 2018-10-18 Cadila Healthcare Limited Novel peptide based pcsk9 vaccine
CN107488215A (zh) * 2017-07-19 2017-12-19 邱志华 人前蛋白转化酶枯草溶菌素9免疫原性肽段及其载体疫苗
TW202142551A (zh) * 2020-01-28 2021-11-16 美商聯合生物醫學公司 針對pcsk9胜肽免疫原及其預防和治療pcsk9介導疾病的製劑
KR20210158693A (ko) * 2020-06-24 2021-12-31 바이오스트림테크놀러지스(주) 항 pcsk9 항체 및 이의 용도
WO2022244845A1 (ja) * 2021-05-19 2022-11-24 国立大学法人熊本大学 脂質異常関連疾患治療薬
AU2023223603A1 (en) 2022-02-28 2024-08-22 Tridem Bioscience Gmbh & Co Kg A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103614375A (zh) * 2006-05-11 2014-03-05 阿尔尼拉姆医药品有限公司 抑制pcsk9基因表达的组合物和方法
EP2137218A2 (en) * 2007-04-13 2009-12-30 Novartis Ag Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9)
AR070316A1 (es) 2008-02-07 2010-03-31 Merck & Co Inc Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
AT507604A1 (de) * 2008-11-19 2010-06-15 Affiris Forschungs & Entwicklungs Gmbh Behandlung von atherosklerose
EP2473605B1 (en) 2009-09-03 2018-04-11 Pfizer Vaccines LLC Pcsk9 vaccine

Also Published As

Publication number Publication date
NZ621439A (en) 2015-06-26
DK2755678T3 (en) 2017-03-13
ES2565757T3 (es) 2016-04-06
BR112014005756A2 (pt) 2017-03-28
ES2618796T3 (es) 2017-06-22
HRP20170328T1 (hr) 2017-05-19
SI2755678T1 (sl) 2017-04-26
HUE028583T2 (en) 2016-12-28
KR101983685B1 (ko) 2019-05-29
AU2012307348A1 (en) 2014-03-20
SMT201600082B (it) 2016-04-29
PT2755678T (pt) 2017-03-24
CN103874504B (zh) 2017-05-31
RS54639B1 (en) 2016-08-31
CY1117335T1 (el) 2017-04-26
RU2017139094A (ru) 2019-02-12
RU2017139094A3 (he) 2019-02-12
SI2570135T1 (sl) 2016-05-31
MX2014002879A (es) 2014-04-10
CN103874504A (zh) 2014-06-18
RU2014114506A (ru) 2015-10-20
EP2570135A1 (en) 2013-03-20
WO2013037889A2 (en) 2013-03-21
KR20140067118A (ko) 2014-06-03
AU2012307348B2 (en) 2017-03-02
US9669079B2 (en) 2017-06-06
CA2848487A1 (en) 2013-03-21
CY1118856T1 (el) 2018-01-10
EP2755678A2 (en) 2014-07-23
IL231043A0 (he) 2014-03-31
EP2570135B1 (en) 2016-01-27
WO2013037889A3 (en) 2013-05-10
IL231043A (he) 2017-05-29
PL2570135T3 (pl) 2016-07-29
AU2012307348B8 (en) 2017-04-06
PL2755678T3 (pl) 2017-08-31
US20160106822A1 (en) 2016-04-21
JP6054400B2 (ja) 2016-12-27
MX346883B (es) 2017-04-05
DK2570135T3 (en) 2016-02-15
US20150071951A1 (en) 2015-03-12
LT2755678T (lt) 2017-03-27
HRP20160392T1 (hr) 2016-05-06
EP2755678B1 (en) 2016-12-21
AU2012307348A8 (en) 2017-04-06
US9220762B2 (en) 2015-12-29
RU2640258C2 (ru) 2017-12-27
JP2014527078A (ja) 2014-10-09
HUE031860T2 (en) 2017-08-28

Similar Documents

Publication Publication Date Title
HK1207967A1 (en) Vaccine
GB201005005D0 (en) New vaccine
EP2683400A4 (en) ADJUVANZIA ON LISTERIA BASE
IL231043A0 (he) תרכיב
EP2876161A4 (en) VACCINE
GB201223386D0 (en) Vaccine
EP2755680A4 (en) PARTICULATE VACCINE FORMULATIONS
GB201119999D0 (en) Vaccine
ZA201402071B (en) Vaccine therapy
GB201014965D0 (en) Vaccine
EP2763699A4 (en) VACCINE
EP2771453A4 (en) DIATOM-BASED VACCINES
ZA201306245B (en) Combination vaccines
GB201120000D0 (en) Vaccine
GB201013006D0 (en) Vaccine
GB201006324D0 (en) Vaccine
ZA201302154B (en) Vaccine
GB201202090D0 (en) Vaccine
GB201121647D0 (en) Vaccine
GB201108256D0 (en) Vaccine
GB201108986D0 (en) Vaccines
GB201108982D0 (en) Vaccines
GB201108984D0 (en) Vaccines
GB201109294D0 (en) Novel vaccine
DK2846829T3 (en) Vaccine combinations